pathway, and induces various cellular responses. TWEAK is a pro-angiogenic and pro-inflammatory cytokine in vivo. Persistent TWEAK–Fn14 engagement or Fn14 overexpression may contribute to acute ...

Targeting JAKs is thought to help suppress overactive cytokine pathways, reducing inflammation — and, as a result, has been used to treat several systemic immune-related inflammatory diseases ...